Status:
UNKNOWN
Diabetic Neuropathy Topical Treatment
Lead Sponsor:
Irmandade da Santa Casa de Misericordia de Sao Paulo
Conditions:
Diabetic Neuropathy
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Comparative study of efficacy and safety of ketamine, clonidine, mixture of both and placebo in patients with diabetic neuropathic pain
Eligibility Criteria
Inclusion
- Diabetes Mellitus type I or II
- Mono or polyneuropathy
- Treatment with Tricyclic Antidepressant, Carbamazepine during 3 weeks at least
- Preserved cognition
Exclusion
- Ulcerative or infection or vesicle lesion in pain site
- Pregnancy
- Breast feeding
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00661063
Start Date
April 1 2008
End Date
June 1 2009
Last Update
April 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Santa Casa de São Paulo
São Paulo, São Paulo, Brazil, 01277-900